Ameritas Investment Partners, Inc. Iveric Bio, Inc. Transaction History

Ameritas Investment Partners, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$26.24 - $39.63 $16,819 - $25,402	641 Added 5.95%	11,408 $448,000
Q4 2022 Feb 13, 2023	BUY	$17.24 - $23.95 $32,324 - $44,906	1,875 Added 21.09%	10,767 $230,000
Q4 2021 Feb 11, 2022	BUY	$13.83 - $18.78 $12,322 - $16,732	891 Added 11.14%	8,892 $149,000
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $8,172 - $20,230	1,156 Added 16.89%	8,001 $130,000
Q3 2020 Nov 13, 2020	BUY	$4.01 - $6.29 $11,468 - $17,989	2,860 Added 71.77%	6,845 $39,000
Q2 2020 Aug 05, 2020	BUY	$3.06 - $6.6 $12,194 - $26,301	3,985 New	3,985 $20,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.